Literature DB >> 1284235

Diagnostic value of analysis of cystatin C and protein HC in biological fluids.

A Grubb1.   

Abstract

Cystatin C, a 13 kDa-protein, is produced by most nucleated cells and is catabolized by the renal tubular cells after passing the glomerular filter. It belongs to the family 2 of the cystatin superfamily of proteins. The function of cystatin C is to regulate the activity of cysteine proteinases and cystatin C seems to be the main cysteine proteinase inhibitor of most investigated human biological fluids. Its normal level in plasma is 0.8-2.5 mg/l, in cerebrospinal fluid 4-14 mg/l and in urine 0.03-0.3 mg/l. The production rate of cystatin C is remarkably constant and its plasma concentration can therefore be used as a reliable measure of the glomerular filtration rate (GFR). Indeed, the cystatin C plasma concentration is more closely correlated to the GFR than the plasma levels of creatinine and all other investigated low molecular weight proteins, including beta 2-microglobulin and retinol binding protein. Protein HC, alias alpha 1-microglobulin, is produced by the liver as a 27 kDa-glycoprotein. It belongs to the lipocalin superfamily of hydrophobic ligand binding proteins and more than 50% of the normal plasma amount of protein HC is present as a high molecular weight HC-IgA complex carrying antibody activity. The plasma concentration of free protein HC is, in contrast to that of HC-IgA, mainly determined by the GFR. The normal values for the plasma concentrations of HC-IgA and free protein HC are 36-620 mg/l and 14-26 mg/l, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284235

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  57 in total

1.  Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children.

Authors:  H Finney; D J Newman; H Thakkar; J M Fell; C P Price
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

2.  A comparison of cystatin C concentrations between patients with chronic interstitial nephritis and glomerular diseases.

Authors:  Nicolas Roberto Robles; Candido Mena; Edgar Chavez; Miguel Angel Bayo; Boris Gonzalez Candia; Antonio Cidoncha; Juan Lopez Gomez; Juan Jose Cubero
Journal:  J Clin Lab Anal       Date:  2017-02-10       Impact factor: 2.352

Review 3.  Glomerular filtration rate measurement and estimation in chronic kidney disease.

Authors:  George J Schwartz; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

4.  Comparison of Effects of Low-Flow Sevoflurane and Low-Flow Desflurane Anaesthesia on Renal Functions Using Cystatin C.

Authors:  Gökçen Duymaz; Seyhan Yağar; Ayşegül Özgök
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-04-01

Review 5.  Screening for chronic kidney disease in HIV-infected patients.

Authors:  Michelle M Estrella; Derek M Fine
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

Review 6.  Biomarkers in nephrology: Core Curriculum 2013.

Authors:  Gearoid M McMahon; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2013-02-27       Impact factor: 8.860

7.  Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients.

Authors:  Eun Hee Kim; Ji Hee Yu; Sang Ah Lee; Eui Young Kim; Won Gu Kim; Seung Hun Lee; Eun Hee Cho; Eun Hee Koh; Woo Je Lee; Min-Seon Kim; Joong-Yeol Park; Ki-Up Lee
Journal:  Korean Diabetes J       Date:  2010-04-30

8.  The impact of demographic characteristics and lifestyle in the distribution of cystatin C values in a healthy greek adult population.

Authors:  Angelos A Evangelopoulos; Natalia G Vallianou; Vassiliki P Bountziouka; Amalia N Giotopoulou; Maria S Bonou; John Barbetseas; Peter C Avgerinos; Demosthenes B Panagiotakos
Journal:  Cardiol Res Pract       Date:  2010-10-14       Impact factor: 1.866

9.  Reference ranges for serum cystatin C measurements in Japanese children by using 4 automated assays.

Authors:  Nahoko Yata; Osamu Uemura; Masataka Honda; Takeshi Matsuyama; Kenji Ishikura; Hiroshi Hataya; Takuhito Nagai; Yohei Ikezumi; Naoya Fujita; Shuichi Ito; Kazumoto Iijima; Mari Saito; Tetsuji Keneko; Teruo Kitagawa
Journal:  Clin Exp Nephrol       Date:  2013-02-28       Impact factor: 2.801

10.  Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy.

Authors:  Wouter J Kikkert; Bimmer E Claessen; Gregg W Stone; Roxana Mehran; Bernhard Witzenbichler; Bruce R Brodie; Jochen Wöhrle; Adam Witkowski; Giulio Guagliumi; Krzysztof Zmudka; José P S Henriques; Jan G P Tijssen; Elias A Sanidas; Vasiliki Chantziara; Ke Xu; George D Dangas
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.